Manali Petrochemicals has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Thursday, May 21, 2026. The meeting has been called to consider the audited financial results of the company—both standalone and consolidated—for the quarter and year ended March 31, 2026. Additionally, the board will deliberate on the recommendation of dividend, if any, for FY2025-26.

Board Meeting Details

The key details of the scheduled board meeting are outlined below:

Trading Window Closure

In accordance with the company's Code of Conduct for Prohibition of Insider Trading, read with SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will continue to remain closed until 48 hours after the announcement of the financial results. This closure was originally communicated to the exchanges vide a letter dated March 25, 2026.

Regulatory Filing

The intimation was submitted to both BSE Limited and the National Stock Exchange of India Limited on May 15, 2026, and was signed by G Sri Vignesh, Company Secretary of Manali Petrochemicals. The filing was made in compliance with Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Manali Petrochemicals has achieved a significant milestone through its subsidiary PennWhite India Private Limited, which successfully inaugurated its manufacturing facility at Oragadam, Chennai, Tamil Nadu on 29 April 2026. This development marks an important expansion in the company's operational capabilities and manufacturing infrastructure for specialty chemicals.

Facility Details and Specifications

The newly opened plant at Oragadam represents a strategic investment by PennWhite India Private Limited to enhance its production capacity for foam control chemistry. The facility is designed to serve customer requirements in India and the wider Asian markets, operating under the same quality and manufacturing standards as PennWhite's existing facility in the United Kingdom.

Corporate Structure and Background

PennWhite India Private Limited operates as a wholly owned step-down subsidiary of Manali Petrochemicals Limited through PennWhite Limited, UK. The UK entity was acquired by Manali Petrochemicals in November 2022, with the Indian subsidiary incorporated in February 2024 to enhance business development in the Indian and broader Asian market.

Leadership Statements

Devaki Muthiah Chardon, Chairperson of PennWhite Limited (UK), emphasized the strategic importance of the facility: "Our PennWhite India plant represents far more than an expansion of our operations. It establishes a strong and strategic presence for PennWhite in Asia, enabling us to better serve our regional customers while opening the door to new partnerships and opportunities."

Tobias Tasche, Chief Executive Officer of PennWhite Limited, UK, highlighted the facility's role in the company's India strategy: "The inauguration of this facility at Oragadam is a significant step in our India strategy. Since MPL's acquisition of PennWhite in 2022, we have steadily expanded our presence — incorporating PennWhite India in 2024, acquiring a defoamer business in India last year, and now commissioning this plant."

Strategic Market Position

The Chennai facility positions PennWhite India to manufacture over 200 products, including foam control agents under the FoamDoctor® brand, silicone oils, and other specialty chemicals. The company serves customers in over 40 countries across applications including food processing, wastewater treatment, printing, oil industry operations, coatings, manufacturing, and construction. The plant has been awarded ISO 9001 certification, with additional quality and food safety accreditations currently underway.